China National Medicines Corporation Ltd, or CNMC, is an important pharmaceutical distribution platform for China National Pharmaceutical Group Co Ltd (Sinopharm) in the Beijing area. 

Over the years, CNMC has adhered to its positioning, fulfilled the responsibilities as a centrally-administered State-owned enterprise, continuously strengthened corporate culture building, actively participated in social civilization practices, and achieved tangible results in the construction of spiritual civilization. In 2021, it was honored with the title of "Beijing Model Unit". 

CNMC and its affiliated enterprises have actively engaged in public welfare activities, donated a total of 1.1 million yuan ($155,080) to welfare institutions over the past five years, dispatched one cadre to participate in the paired assistance program in Xizang autonomous region, and donated various COVID-19 prevention materials worth over 1 million yuan to medical institutions and local communities during the pandemic. 

The company promotes green development by planning voluntary tree planting, establishing green factories, and constructing green parks. Over the past 20 years, CNMC has organized 210 person-time employees for voluntary blood donation and volunteers of nearly a thousand person-times in assisting local COVID-19 prevention and control and street environmental improvement, as well as conducted over 100 free clinics and public health lectures, leading a new social trend through practical actions. 

CNMC has released an annual corporate social responsibility report for 13 consecutive years, and compiled a corporate culture manual, enterprise stories and an anti-pandemic collection.